P C Allgood1, M Bachmann. 1. Department of Social Medicine, MRC Health Services Research Collaboration, University of Bristol, United Kingdom.
Abstract
OBJECTIVE: To compare the effectiveness of medical (antacids, histamine antagonists and proton pump inhibitors) and surgical (fundoplication) treatment of chronic GORD. SUBJECTS: Patients with objective (endoscopic or pH) evidence of chronic reflux reported in 6 randomised trials and 3 cohort studies, 1966-1999. METHODS: Systematic review of comparative studies identified from electronic searches, citations, manual searches of journals, and correspondence with authors and experts. MAIN OUTCOME MEASURES: Improvements in prevalence or severity of symptoms, oesophagitis, pH reflux duration, lower oesophageal sphincter pressure, patients' satisfaction, and side-effects. RESULTS: Improved outcomes were more common after surgical than medical treatment with significant differences in objective outcomes in 5/6 randomised trials and in 2/3 cohort studies. Subjective outcomes (symptoms and patients' satisfaction) were also more common among surgical patients in all but one study that assessed them. Odds ratios for improvement with surgical rather than medical treatment ranged from 1.2 to 200, and numbers needed to treat ranged from 1.2 to 58, where these could be calculated. Studies were too heterogeneous for meta-analysis. CONCLUSIONS: In trials of chronic severe GORD, surgery is consistently more effective than medical treatment in relieving symptoms and objective oesophagitis, although omeprazole can give similar symptom relief with adjustment of the dose.
OBJECTIVE: To compare the effectiveness of medical (antacids, histamine antagonists and proton pump inhibitors) and surgical (fundoplication) treatment of chronic GORD. SUBJECTS:Patients with objective (endoscopic or pH) evidence of chronic reflux reported in 6 randomised trials and 3 cohort studies, 1966-1999. METHODS: Systematic review of comparative studies identified from electronic searches, citations, manual searches of journals, and correspondence with authors and experts. MAIN OUTCOME MEASURES: Improvements in prevalence or severity of symptoms, oesophagitis, pH reflux duration, lower oesophageal sphincter pressure, patients' satisfaction, and side-effects. RESULTS: Improved outcomes were more common after surgical than medical treatment with significant differences in objective outcomes in 5/6 randomised trials and in 2/3 cohort studies. Subjective outcomes (symptoms and patients' satisfaction) were also more common among surgical patients in all but one study that assessed them. Odds ratios for improvement with surgical rather than medical treatment ranged from 1.2 to 200, and numbers needed to treat ranged from 1.2 to 58, where these could be calculated. Studies were too heterogeneous for meta-analysis. CONCLUSIONS: In trials of chronic severe GORD, surgery is consistently more effective than medical treatment in relieving symptoms and objective oesophagitis, although omeprazole can give similar symptom relief with adjustment of the dose.
Authors: Bart P L Witteman; Jose M Conchillo; Nicolaas F Rinsma; Bark Betzel; Andrea Peeters; Ger H Koek; Laurents P S Stassen; Nicole D Bouvy Journal: Am J Gastroenterol Date: 2015-03-31 Impact factor: 10.864
Authors: Guy-Bernard Cadière; Nathalie Van Sante; Jaime E Graves; Anna K Gawlicka; Amin Rajan Journal: Surg Endosc Date: 2009-03-14 Impact factor: 4.584
Authors: Guy-Bernard Cadière; Michel Buset; Vinciane Muls; Amin Rajan; Thomas Rösch; Alexander J Eckardt; Joseph Weerts; Boris Bastens; Guido Costamagna; Michele Marchese; Hubert Louis; Fazia Mana; Filip Sermon; Anna K Gawlicka; Michael A Daniel; Jacques Devière Journal: World J Surg Date: 2008-08 Impact factor: 3.352